436 related articles for article (PubMed ID: 22461910)
1. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
[TBL] [Abstract][Full Text] [Related]
2. Quantitative study of epigenetic signature in head and neck squamous cell carcinoma.
Umair A; Tarakji B; Ibrahim A; Nasser A; Fq A; Shreen A
Turk J Med Sci; 2015; 45(2):372-86. PubMed ID: 26084130
[TBL] [Abstract][Full Text] [Related]
3. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
[TBL] [Abstract][Full Text] [Related]
5. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
Waseem A; Ali M; Odell EW; Fortune F; Teh MT
Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
7. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer.
Demokan S; Chuang A; Suoğlu Y; Ulusan M; Yalnız Z; Califano JA; Dalay N
Head Neck; 2012 Oct; 34(10):1470-5. PubMed ID: 22106032
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
11. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
12. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
13. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
16. The effect of acute dichlorodiphenyltrichloroethane exposure on hypermethylation status and down-regulation of p53 and p16INK4a genes in rat liver.
Kostka G; Urbanek-Olejnik K; Liszewska M; Winczura A
Environ Toxicol; 2016 May; 31(5):584-92. PubMed ID: 25410620
[TBL] [Abstract][Full Text] [Related]
17. Dietary folate is associated with p16(INK4A) methylation in head and neck squamous cell carcinoma.
Kraunz KS; Hsiung D; McClean MD; Liu M; Osanyingbemi J; Nelson HH; Kelsey KT
Int J Cancer; 2006 Oct; 119(7):1553-7. PubMed ID: 16646054
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
Zhu YZ; Zhu R; Shi LG; Mao Y; Zheng GJ; Chen Q; Zhu HG
Exp Mol Pathol; 2010 Dec; 89(3):268-75. PubMed ID: 20620135
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis.
Zhu YZ; Zhu R; Fan J; Pan Q; Li H; Chen Q; Zhu HG
J Viral Hepat; 2010 Feb; 17(2):98-107. PubMed ID: 19732323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
